Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmenopausal Women Article

sustainable development goals

authors

publication date

  • June 1, 2017

webpage

published in

keywords

  • 17-beta estradiol
  • age
  • body mass index
  • dyspareunia
  • vaginal atrophy

start page

  • 616

end page

  • 623

volume

  • 26

issue

  • 6